This selection from the NCCN Guidelines for Merkel Cell Carcinoma (MCC) focuses on
areas impacted by recently emerging data, including sections describing MCC risk factors …

Cancer is the second leading cause of death worldwide and the morbidity is growing in
developed countries. According to WHO,> 14 million people per year are diagnosed with …

Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine tumor
with a higher mortality rate than melanoma. Approximately 40% of MCC patients have nodal …

Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein-1 (PD-
1)/programmed cell death ligand-1 (PD-L1) frequently induces tumor response in metastatic …

Merkel cell carcinoma (MCC, ICD‐O M8247/3) is a rare malignant primary skin tumor with
epithelial and neuroendocrine differentiation. The neoplastic cells share many …

Background Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin tumor.
Currently, 18 F-fluoro-deoxy-glucose (18 F-FDG) PET/CT is the functional imaging modality …

Introduction TROG 09.03 prospectively studied the utility of Fluorine‐18 Fluorodeoxyglucose
(18‐FDG) PET in the management of Merkel cell carcinoma of skin. Methods Following …

Simple Summary There is currently no consensus on a widely accepted algorithm for
imaging Merkel cell carcinoma (MCC) patients. Baseline, tomographic imaging is not …

Combined positron-emission tomography and computed tomography (PET-CT) has taken
the oncological world by storm since being introduced into the clinical domain in the early 21 …

Merkel cell carcinoma is a rare, aggressive neuroendocrine skin malignancy. Evidence for
management comes from case series and single-arm trials. Optimal outcomes require …